Image of the Day: Coronavirus Samples

The University of Washington department of laboratory medicine in Seattle processes a backlog of COVID-19 samples.

Written byAmy Schleunes
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The University of Washington department of virology sent out a note of thanks after workers and volunteers in Specimen Processing Services came together over the weekend to process COVID-19 samples. On March 14, the lab processed 2,360 samples, approximately 8 percent of which were positive, and on March 15, they tested another roughly 2,000 samples, mostly from western Washington, and found that about 6.5 percent were positive. The lab is operating at full capacity during the coronavirus pandemic and as of March 16 is only able to accept samples from established clients.

The public health department in King County, Washington, which includes Seattle, reports 488 confirmed coronavirus cases and 43 deaths as of March 16. A coronavirus vaccine clinical trial is now underway in Seattle, which National Institute of Allergy and Infectious Diseases director Anthony Fauci said has been “launched in record speed.”

Amy Schleunes is an intern at The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies